IL23R and breast carcinoma: In addition to its role in SCC, IL-23 promotes tumor progression by the inhibition of apoptosis in breast cancer cell lines (26), and levels of IL-23 and IL-23R expression are positively correlated with tumor size, tumor-node-metastasis stage, and metastasis in breast cancer (26).